Linagliptin(CAS: 668270-12-0)

Linagliptin is a pharmaceutical compound with the CAS number 668270-12-0. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor used primarily in the treatment of type 2 diabetes. Its chemical formula is C16H21N3O3S, and it is a white to off-white solid at room temperature with good solubility in dimethyl sulfoxide (DMSO).

Linagliptin is mainly used as a medication to manage blood sugar levels in patients with type 2 diabetes. It works by inhibiting the enzyme DPP-4, which helps increase the levels of incretin hormones that stimulate insulin production. It is also used in research for studying metabolic disorders and as an active pharmaceutical ingredient in drug formulations.

Linagliptin is generally considered safe when used as directed under medical supervision. It has a favorable safety profile with minimal side effects, though precautions should be taken in patients with severe kidney disease. Safety standards are in place to ensure proper handling and administration in pharmaceutical settings.

Linagliptin should be stored in a cool, dry place away from moisture and light. It is typically kept at room temperature (15-30°C) and protected from humidity. Proper storage ensures its stability and efficacy over time, as specified by pharmaceutical guidelines.